Sunshine Biopharma, Inc.
SBFM
$1.48
$0.085.71%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -23.76% | -10.45% | -52.99% | -40.55% | -35.23% |
| Total Receivables | 29.11% | -9.71% | 21.84% | 51.56% | 58.24% |
| Inventory | 43.20% | 53.33% | 54.03% | 96.66% | 117.42% |
| Prepaid Expenses | -40.00% | -47.12% | 12.86% | 264.87% | 1,856.91% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 7.64% | 8.17% | -15.09% | 4.32% | 2.15% |
|
|
|||||
| Total Current Assets | 7.64% | 8.17% | -15.09% | 4.32% | 2.15% |
| Net Property, Plant & Equipment | 25.28% | 38.53% | 41.80% | 46.37% | 13.32% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -31.72% | 1.79% | 54.59% | 109.08% | 141.96% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 4.76% | 9.09% | -8.50% | 11.75% | 8.70% |
|
|
|||||
| Total Accounts Payable | 47.63% | -2.69% | 38.98% | 114.39% | 87.19% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 87.53% | 94.32% | 85.44% | 75.06% | -1.27% |
| Total Finance Division Other Current Liabilities | 16.00% | 117.25% | -81.31% | -80.19% | -90.73% |
| Total Other Current Liabilities | 16.00% | 117.25% | -81.31% | -80.19% | -90.73% |
| Total Current Liabilities | 46.88% | 5.18% | -11.80% | 13.75% | -11.00% |
|
|
|||||
| Total Current Liabilities | 46.88% | 5.18% | -11.80% | 13.75% | -11.00% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 44.61% | 52.62% | 45.31% | 38.16% | -20.77% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | 13.26% |
| Total Liabilities | 45.25% | 8.08% | -8.40% | 14.98% | -11.77% |
|
|
|||||
| Common Stock & APIC | 6.15% | 8.39% | 4.31% | 10.59% | 8.68% |
| Retained Earnings | -8.96% | -9.60% | -7.72% | -8.03% | -6.74% |
| Treasury Stock & Other | -290.27% | 141.11% | -627.43% | -219.24% | -17.56% |
| Total Common Equity | -3.36% | 9.35% | -8.53% | 10.76% | 13.95% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | 0.00% | 0.00% | 0.00% | 1,200.00% | 1,200.00% |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 1,200.00% | 1,200.00% |
|
|
|||||
| Total Common Equity | -3.36% | 9.35% | -8.53% | 10.76% | 13.95% |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 1,200.00% | 1,200.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -3.35% | 9.34% | -8.53% | 10.81% | 14.00% |
|
|
|||||